Novavax Inc vs ON Holding AG — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while ON Holding AG trades at $37.31 (market cap $12.55B). The key difference: ON Holding AG is far larger — about 9.7× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| NVAX | ONON | |
|---|---|---|
Market Cap | $1.30B | $12.55B |
Sector | Health | Technology |
52-Week High | $11.19 | $53.21 |
52-Week Low | $6.22 | $31.88 |
Enterprise Value | $800.50M | $11.87B |
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →